4//SEC Filing
Brams Matthew 4
Accession 0001493152-24-023766
CIK 0001862150other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 7:59 PM ET
Size
5.8 KB
Accession
0001493152-24-023766
Insider Transaction Report
Form 4
Cingulate Inc.CING
Brams Matthew
EVP and Chief Medical Officer
Transactions
- Award
Stock Option (right to Buy)
2024-06-11+63,324→ 63,324 totalExercise: $1.18Exp: 2034-03-04→ Common Stock (63,324 underlying)
Footnotes (2)
- [F1]The stock option grant was approved by Cingulate Inc.'s board of directors on March 4, 2024, subject to stockholder approval of Amendment No.1 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan (the "Amendment"). Cingulate's stockholders approved the Amendment on June 11, 2024.
- [F2]The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 30-month period following the initial vesting date.
Documents
Issuer
Cingulate Inc.
CIK 0001862150
Entity typeother
Related Parties
1- filerCIK 0001884361
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 7:59 PM ET
- Size
- 5.8 KB